Screener / SEC EDGAR /CIK 0001551306 /10-K filed Feb 27, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Health Services

Progyny, Inc. PGNY

Compare with peers Embed

PGNY among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+10.4%80th of 155 · median +10.5%
Net margin
-4.1%15.3%
6.8%77th of 154 · median 6.8%
Return on equity
-5.2%18.5%
22.0%24th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
13.4%58th of 145 · median 10.0%

PGNY and 9 peers, year by year

The 9 Health care companies closest to PGNY in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
PGNY Progyny, Inc. FY2025 $1.3B+10.4%23.6%6.6%4.5%14.9%11.3%-
HAE Haemonetics Corp FY2026 $1.3B−2.0%59.0%11.7%7.3%19.5%12.2%1.56
GH Guardant Health, Inc. FY2025 $982.0M+32.9%-−44.5%−42.4%−23.7%n/mn/m
MDGL Madrigal Pharmaceuticals, Inc. FY2025 $958.4M+432%-−31.3%−30.1%−19.8%−47.8%0.56
SHC Sotera Health Co FY2025 $1.2B+5.7%55.5%-6.7%12.8%12.9%3.53
TECH Bio-Techne FY2026 $1.2B−0.4%65.8%20.7%15.0%21.7%8.6%0.09
ACAD Acadia Pharmaceuticals Inc FY2025 $1.1B+11.9%-9.8%36.5%9.8%31.9%-
ADUS Addus HomeCare Corp FY2025 $1.4B+23.2%32.5%9.7%6.7%7.3%8.8%0.11
LIVN LivaNova PLC FY2025 $1.4B+10.7%67.7%14.4%−17.5%12.5%−20.2%0.31
PBH Prestige Consumer Healthcare Inc. FY2026 $1.1B−4.3%54.7%28.4%17.5%22.6%10.1%0.53

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2017 to FY2025 · 10-K XBRL

PGNYProgyny, Inc.
FY2017 revenue $48.6MFY2018 revenue $105.4MFY2019 revenue $229.7MFY2020 revenue $344.9MFY2021 revenue $500.6MFY2022 revenue $786.9MFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.3B FY2017 net margin −25.6%FY2018 net margin 0.6%FY2019 net margin −3.7%FY2020 net margin 13.5%FY2021 net margin 13.1%FY2022 net margin 3.9%FY2023 net margin 5.7%FY2024 net margin 4.7%FY2025 net margin 4.5% FY2017FY2025
Revenue$1.3B Growth+10.4% Net margin4.5%
HAEHaemonetics Corp
FY2017 revenue $886.1MFY2018 revenue $903.9MFY2019 revenue $967.6MFY2020 revenue $988.5MFY2021 revenue $870.5MFY2022 revenue $993.2MFY2023 revenue $1.2BFY2024 revenue $1.3BFY2025 revenue $1.4B FY2017 net margin −3.0%FY2018 net margin 5.0%FY2019 net margin 5.7%FY2020 net margin 7.7%FY2021 net margin 9.1%FY2022 net margin 4.4%FY2023 net margin 9.9%FY2024 net margin 9.0%FY2025 net margin 12.3% FY2017FY2025
Revenue$1.4B Growth+4.0% Net margin12.3%
GHGuardant Health, Inc.
FY2017 revenue $49.8MFY2018 revenue $90.6MFY2019 revenue $214.4MFY2020 revenue $286.7MFY2021 revenue $373.7MFY2022 revenue $449.5MFY2023 revenue $563.9MFY2024 revenue $739.0MFY2025 revenue $982.0M FY2017 net margin −167.0%FY2018 net margin −93.8%FY2019 net margin −35.3%FY2020 net margin −88.5%FY2021 net margin −103.0%FY2022 net margin −145.6%FY2023 net margin −85.0%FY2024 net margin −59.0%FY2025 net margin −42.4% FY2017FY2025
Revenue$982.0M Growth+32.9% Net margin−42.4%
MDGLMadrigal Pharmaceuticals, Inc.
FY2024 revenue $180.1MFY2025 revenue $958.4M FY2024 net margin −258.6%FY2025 net margin −30.1% FY2017FY2025
Revenue$958.4M Growth+432% Net margin−30.1%
SHCSotera Health Co
FY2019 revenue $778.3MFY2020 revenue $818.2MFY2021 revenue $931.5MFY2022 revenue $1.0BFY2023 revenue $1.0BFY2024 revenue $1.1BFY2025 revenue $1.2B FY2019 net margin −2.7%FY2020 net margin −4.7%FY2021 net margin 12.5%FY2022 net margin −23.3%FY2023 net margin 4.9%FY2024 net margin 4.0%FY2025 net margin 6.7% FY2017FY2025
Revenue$1.2B Growth+5.7% Net margin6.7%
TECHBio-Techne
FY2017 revenue $563.0MFY2018 revenue $643.0MFY2019 revenue $714.0MFY2020 revenue $738.7MFY2021 revenue $931.0MFY2022 revenue $1.1BFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.2B FY2017 net margin 13.5%FY2018 net margin 19.6%FY2019 net margin 13.5%FY2020 net margin 31.0%FY2021 net margin 15.1%FY2022 net margin 24.6%FY2023 net margin 25.1%FY2024 net margin 14.5%FY2025 net margin 6.0% FY2017FY2025
Revenue$1.2B Growth+5.2% Net margin6.0%
ACADAcadia Pharmaceuticals Inc
FY2017 revenue $124.9MFY2018 revenue $223.8MFY2019 revenue $339.1MFY2020 revenue $441.8MFY2021 revenue $484.1MFY2022 revenue $517.2MFY2023 revenue $726.4MFY2024 revenue $957.8MFY2025 revenue $1.1B FY2017 net margin −231.7%FY2018 net margin −109.6%FY2019 net margin −69.4%FY2020 net margin −63.7%FY2021 net margin −34.7%FY2022 net margin −41.8%FY2023 net margin −8.4%FY2024 net margin 23.6%FY2025 net margin 36.5% FY2017FY2025
Revenue$1.1B Growth+11.9% Net margin36.5%
ADUSAddus HomeCare Corp
FY2017 revenue $426.0MFY2018 revenue $516.6MFY2019 revenue $648.8MFY2020 revenue $764.8MFY2021 revenue $864.5MFY2022 revenue $951.1MFY2023 revenue $1.1BFY2024 revenue $1.2BFY2025 revenue $1.4B FY2017 net margin 2.8%FY2018 net margin 3.2%FY2019 net margin 3.9%FY2020 net margin 4.3%FY2021 net margin 5.2%FY2022 net margin 4.8%FY2023 net margin 5.9%FY2024 net margin 6.4%FY2025 net margin 6.7% FY2017FY2025
Revenue$1.4B Growth+23.2% Net margin6.7%
LIVNLivaNova PLC
FY2017 revenue $1.0BFY2018 revenue $1.1BFY2019 revenue $1.1BFY2020 revenue $934.2MFY2021 revenue $1.0BFY2022 revenue $1.0BFY2023 revenue $1.2BFY2024 revenue $1.3BFY2025 revenue $1.4B FY2017 net margin −2.5%FY2018 net margin −17.1%FY2019 net margin −14.5%FY2020 net margin −37.3%FY2021 net margin −13.1%FY2022 net margin −8.4%FY2023 net margin 1.5%FY2024 net margin 5.0%FY2025 net margin −17.5% FY2017FY2025
Revenue$1.4B Growth+10.7% Net margin−17.5%
PBHPrestige Consumer Healthcare Inc.
FY2017 revenue $882.1MFY2018 revenue $1.0BFY2019 revenue $975.8MFY2020 revenue $963.0MFY2021 revenue $943.4MFY2022 revenue $1.1BFY2023 revenue $1.1BFY2024 revenue $1.1BFY2025 revenue $1.1B FY2017 net margin 7.9%FY2018 net margin 32.6%FY2019 net margin −3.7%FY2020 net margin 14.8%FY2021 net margin 17.5%FY2022 net margin 18.9%FY2023 net margin −7.3%FY2024 net margin 18.6%FY2025 net margin 18.9% FY2017FY2025
Revenue$1.1B Growth+1.1% Net margin18.9%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2017 to FY2025

Revenue as reported in the 10-K.

$0 $1.4B FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: $886.1M, $903.9M, $967.6M, $988.5M, $870.5M, $993.2M, $1.2B, $1.3B, $1.4B HAE GH: $49.8M, $90.6M, $214.4M, $286.7M, $373.7M, $449.5M, $563.9M, $739.0M, $982.0M GH MDGL: $0, $0, $0, $0, $0, $0, $0, $180.1M, $958.4M MDGL SHC: -, -, $778.3M, $818.2M, $931.5M, $1.0B, $1.0B, $1.1B, $1.2B SHC TECH: $563.0M, $643.0M, $714.0M, $738.7M, $931.0M, $1.1B, $1.1B, $1.2B, $1.2B TECH ACAD: $124.9M, $223.8M, $339.1M, $441.8M, $484.1M, $517.2M, $726.4M, $957.8M, $1.1B ACAD ADUS: $426.0M, $516.6M, $648.8M, $764.8M, $864.5M, $951.1M, $1.1B, $1.2B, $1.4B ADUS LIVN: $1.0B, $1.1B, $1.1B, $934.2M, $1.0B, $1.0B, $1.2B, $1.3B, $1.4B LIVN PBH: $882.1M, $1.0B, $975.8M, $963.0M, $943.4M, $1.1B, $1.1B, $1.1B, $1.1B PBH PGNY: $48.6M, $105.4M, $229.7M, $344.9M, $500.6M, $786.9M, $1.1B, $1.2B, $1.3B PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from $0 to $1.4B. A gap is a year with no number. A ring marks where a line starts: SHC has no earlier 10-K here.

Sales growth, FY2017 to FY2025

Revenue against the fiscal year before.

−13.8% +621% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: -, +2.0%, +7.0%, +2.2%, −11.9%, +14.1%, +17.7%, +12.0%, +4.0% HAE GH: +97.4%, +81.9%, +137%, +33.8%, +30.3%, +20.3%, +25.5%, +31.0%, +32.9% GH MDGL: -, -, -, -, -, -, -, -, +432% MDGL SHC: -, -, -, +5.1%, +13.9%, +7.8%, +4.5%, +4.9%, +5.7% SHC TECH: +12.8%, +14.2%, +11.0%, +3.5%, +26.0%, +18.7%, +2.8%, +2.0%, +5.2% TECH ACAD: +621%, +79.2%, +51.5%, +30.3%, +9.6%, +6.8%, +40.4%, +31.8%, +11.9% ACAD ADUS: +6.3%, +21.3%, +25.6%, +17.9%, +13.0%, +10.0%, +11.3%, +9.1%, +23.2% ADUS LIVN: +4.9%, +9.4%, −2.1%, −13.8%, +10.8%, −1.3%, +12.9%, +8.7%, +10.7% LIVN PBH: +9.4%, +18.0%, −6.3%, −1.3%, −2.0%, +15.2%, +3.8%, −0.2%, +1.1% PBH PGNY: -, +117%, +118%, +50.1%, +45.2%, +57.2%, +38.3%, +7.2%, +10.4% PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −13.8% to +621%. A gap is a year with no number. A ring marks where a line starts: PGNY, HAE, MDGL, SHC have no earlier 10-K here.

Gross margin, FY2017 to FY2025

Gross profit / revenue.

15.2% 98.0% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: 42.7%, 45.6%, 43.2%, 49.0%, 45.7%, 50.9%, 52.6%, 52.8%, 55.0% HAE SHC: -, -, 50.8%, 54.2%, 55.7%, 55.5%, 55.0%, 54.7%, 55.5% SHC TECH: 66.5%, 67.2%, 66.3%, 65.4%, 68.0%, 68.4%, 67.7%, 66.4%, 64.8% TECH ACAD: 92.7%, 94.5%, 96.7%, 97.7%, 97.8%, 98.0%, 94.3%, -, - ACAD ADUS: 27.2%, 26.5%, 27.6%, 29.6%, 31.2%, 31.5%, 32.1%, 32.5%, 32.5% ADUS LIVN: 64.4%, -, 66.8%, 63.7%, 68.2%, 69.2%, 65.5%, 68.1%, 67.7% LIVN PBH: 56.7%, 55.4%, 56.9%, 57.3%, 58.0%, 57.1%, 55.4%, 55.5%, 55.8% PBH PGNY: 15.2%, 18.4%, 19.8%, 20.3%, 22.4%, 21.3%, 21.9%, 21.7%, 23.6% PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 15.2% to 98.0%. A gap is a year with no number. A ring marks where a line starts: SHC has no earlier 10-K here.

Operating margin, FY2017 to FY2025

Operating income / revenue.

−276.4% 31.5% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: −2.2%, 6.2%, 8.6%, 10.5%, 10.3%, 8.1%, 13.4%, 12.6%, 16.3% HAE GH: −153.7%, −102.5%, −38.4%, −88.9%, −110.0%, −121.1%, −100.1%, −60.0%, −44.5% GH MDGL: -, -, -, -, -, -, -, −276.4%, −31.3% MDGL SHC: -, -, 23.6%, 25.2%, 27.6%, 24.7%, 26.4%, 27.0%, - SHC TECH: 21.4%, 21.2%, 20.5%, 21.3%, 25.5%, 26.8%, 26.3%, 17.8%, 8.4% TECH ACAD: −234.1%, −110.6%, −72.7%, −64.9%, −35.2%, −43.2%, −10.1%, 24.1%, 9.8% ACAD ADUS: 5.9%, 4.4%, 5.4%, 5.8%, 7.6%, 7.2%, 8.6%, 8.9%, 9.7% ADUS LIVN: 9.5%, −22.4%, −15.8%, −29.3%, −0.1%, −7.5%, −5.9%, 10.3%, 14.4% LIVN PBH: 23.3%, 20.7%, 6.9%, 30.2%, 31.5%, 30.4%, −2.0%, 30.4%, 29.6% PBH PGNY: −22.7%, −3.3%, 4.2%, 2.4%, 6.5%, 3.0%, 5.7%, 5.8%, 6.6% PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −276.4% to 31.5%. A gap is a year with no number. A ring marks where a line starts: MDGL, SHC have no earlier 10-K here.

Net margin, FY2017 to FY2025

Net income / revenue.

−258.6% 36.5% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: −3.0%, 5.0%, 5.7%, 7.7%, 9.1%, 4.4%, 9.9%, 9.0%, 12.3% HAE GH: −167.0%, −93.8%, −35.3%, −88.5%, −103.0%, −145.6%, −85.0%, −59.0%, −42.4% GH MDGL: -, -, -, -, -, -, -, −258.6%, −30.1% MDGL SHC: -, -, −2.7%, −4.7%, 12.5%, −23.3%, 4.9%, 4.0%, 6.7% SHC TECH: 13.5%, 19.6%, 13.5%, 31.0%, 15.1%, 24.6%, 25.1%, 14.5%, 6.0% TECH ACAD: −231.7%, −109.6%, −69.4%, −63.7%, −34.7%, −41.8%, −8.4%, 23.6%, 36.5% ACAD ADUS: 2.8%, 3.2%, 3.9%, 4.3%, 5.2%, 4.8%, 5.9%, 6.4%, 6.7% ADUS LIVN: −2.5%, −17.1%, −14.5%, −37.3%, −13.1%, −8.4%, 1.5%, 5.0%, −17.5% LIVN PBH: 7.9%, 32.6%, −3.7%, 14.8%, 17.5%, 18.9%, −7.3%, 18.6%, 18.9% PBH PGNY: −25.6%, 0.6%, −3.7%, 13.5%, 13.1%, 3.9%, 5.7%, 4.7%, 4.5% PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −258.6% to 36.5%. A gap is a year with no number. A ring marks where a line starts: MDGL, SHC have no earlier 10-K here.

Free cash flow, FY2017 to FY2025

Cash from operations minus capital spending.

−$457.0M $307.9M FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: $83.6M, $145.6M, $40.3M, $109.5M, $71.8M, $75.8M, $81.7M, $143.6M, $142.4M HAE GH: −$78.9M, −$92.4M, −$65.9M, −$140.1M, −$284.1M, −$386.9M, −$345.5M, −$274.9M, −$233.1M GH MDGL: −$22.4M, −$25.5M, −$41.8M, −$157.9M, −$184.1M, −$225.1M, −$325.7M, −$457.0M, −$190.0M MDGL SHC: -, -, $91.8M, $67.1M, $179.4M, $95.6M, −$362.7M, $45.1M, $149.2M SHC TECH: $128.5M, $149.4M, $156.2M, $153.5M, $307.9M, $280.4M, $216.1M, $236.1M, $256.6M TECH ACAD: −$218.6M, −$169.6M, −$152.3M, −$143.8M, −$126.8M, −$114.0M, $16.7M, $157.2M, $105.1M ACAD ADUS: $49.2M, $27.9M, $7.4M, $102.6M, $34.8M, $96.8M, $102.8M, $110.4M, $103.8M ADUS LIVN: $58.4M, $83.3M, −$115.8M, −$114.4M, $77.1M, $43.4M, $39.9M, $135.9M, $173.3M LIVN PBH: $145.7M, $197.6M, $178.8M, $202.6M, $213.4M, $250.3M, $221.9M, $239.4M, $243.3M PBH PGNY: −$10.1M, $1.7M, −$4.5M, $35.2M, $23.9M, $77.2M, $185.2M, $173.7M, $191.8M PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$457.0M to $307.9M. A gap is a year with no number. A ring marks where a line starts: SHC has no earlier 10-K here.

FCF margin, FY2017 to FY2025

Free cash flow / revenue.

−253.7% 33.1% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: 9.4%, 16.1%, 4.2%, 11.1%, 8.2%, 7.6%, 7.0%, 11.0%, 10.5% HAE GH: −158.3%, −101.9%, −30.7%, −48.9%, −76.0%, −86.1%, −61.3%, −37.2%, −23.7% GH MDGL: -, -, -, -, -, -, -, −253.7%, −19.8% MDGL SHC: -, -, 11.8%, 8.2%, 19.3%, 9.5%, −34.6%, 4.1%, 12.8% SHC TECH: 22.8%, 23.2%, 21.9%, 20.8%, 33.1%, 25.4%, 19.0%, 20.4%, 21.0% TECH ACAD: −175.0%, −75.8%, −44.9%, −32.5%, −26.2%, −22.0%, 2.3%, 16.4%, 9.8% ACAD ADUS: 11.5%, 5.4%, 1.1%, 13.4%, 4.0%, 10.2%, 9.7%, 9.6%, 7.3% ADUS LIVN: 5.8%, 7.5%, −10.7%, −12.3%, 7.4%, 4.2%, 3.5%, 10.8%, 12.5% LIVN PBH: 16.5%, 19.0%, 18.3%, 21.0%, 22.6%, 23.0%, 19.7%, 21.3%, 21.4% PBH PGNY: −20.8%, 1.6%, −2.0%, 10.2%, 4.8%, 9.8%, 17.0%, 14.9%, 14.9% PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −253.7% to 33.1%. A gap is a year with no number. A ring marks where a line starts: MDGL, SHC have no earlier 10-K here.

Return on equity, FY2017 to FY2025

Net income / shareholders' equity at the year end.

−149.6% 31.9% FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: −3.6%, 6.1%, 8.2%, 13.0%, 10.9%, 5.8%, 14.1%, 12.2%, 20.4% HAE GH: −27.0%, −17.6%, −9.5%, −19.5%, −59.7%, n/m, n/m, n/m, n/m GH MDGL: −17.1%, −6.9%, −20.2%, −84.3%, −123.3%, −149.6%, −92.2%, −61.8%, −47.8% MDGL SHC: -, -, n/m, −8.5%, 19.9%, −66.7%, 11.6%, 11.0%, 12.9% SHC TECH: 8.0%, 11.7%, 8.2%, 16.6%, 9.0%, 16.0%, 14.5%, 8.1%, 3.8% TECH ACAD: −86.3%, −51.2%, −33.7%, −44.9%, −31.0%, −53.9%, −14.2%, 30.9%, 31.9% ACAD ADUS: 7.0%, 6.1%, 5.3%, 6.4%, 7.9%, 7.3%, 8.8%, 7.6%, 8.8% ADUS LIVN: −1.4%, −12.6%, −11.4%, −31.4%, −10.5%, −7.1%, 1.4%, 4.8%, −20.2% LIVN PBH: 8.4%, 28.8%, −3.3%, 12.2%, 12.1%, 13.0%, −5.7%, 12.6%, 11.7% PBH PGNY: n/m, n/m, −7.5%, 27.8%, 26.1%, 8.1%, 11.2%, 12.9%, 11.3% PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −149.6% to 31.9%. A gap is a year with no number. A ring marks where a line starts: PGNY, SHC have no earlier 10-K here.

Debt / equity, FY2017 to FY2025

Total debt / shareholders' equity at the year end.

0.00 5.55 FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: 0.43, 0.34, 0.52, 0.65, 0.97, 1.03, 0.94, 0.84, 1.49 HAE MDGL: -, -, -, -, 0.00, 0.35, 0.28, 0.16, 0.56 MDGL SHC: -, -, -, 4.03, 2.97, 5.55, 5.02, 5.49, 3.53 SHC TECH: 0.36, 0.31, 0.43, 0.26, 0.22, 0.15, 0.18, 0.15, 0.18 TECH ADUS: 0.25, 0.06, 0.13, 0.38, 0.38, 0.21, 0.18, 0.23, 0.11 ADUS LIVN: 0.08, 0.11, 0.25, 0.59, 0.19, 0.45, 0.46, 0.48, 0.31 LIVN PBH: 2.67, 1.69, 1.64, 1.48, 1.09, 0.94, 0.93, 0.68, 0.54 PBH
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 5.55. A gap is a year with no number. A ring marks where a line starts: MDGL, SHC have no earlier 10-K here.
CompanyFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
PGNY Dec -n/m-------
HAE Mar 0.430.340.520.650.971.030.940.841.49
GH Dec -------n/mn/m
MDGL Dec ----0.000.350.280.160.56
SHC Dec ---4.032.975.555.025.493.53
TECH Jun 0.360.310.430.260.220.150.180.150.18
ACAD Dec ---------
ADUS Dec 0.250.060.130.380.380.210.180.230.11
LIVN Dec 0.080.110.250.590.190.450.460.480.31
PBH Mar 2.671.691.641.481.090.940.930.680.54
Peer median0.360.310.430.620.380.450.460.480.54

EPS (diluted), FY2017 to FY2025

Diluted earnings per share, on today's share count after splits.

−$21.90 $6.34 FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 HAE: −$0.51, $0.85, $1.04, $1.48, $1.55, $0.84, $2.24, $2.29, $3.31 HAE GH: −$7.07, −$2.80, −$0.84, −$2.60, −$4.00, −$6.41, −$4.28, −$3.56, −$3.32 GH MDGL: −$2.54, −$2.22, −$5.45, −$13.09, −$14.63, −$17.23, −$19.99, −$21.90, −$12.85 MDGL SHC: -, -, −$0.09, −$0.16, $0.41, −$0.83, $0.18, $0.16, $0.27 SHC TECH: $0.51, $0.83, $0.62, $1.46, $0.87, $1.66, $1.76, $1.05, $0.46 TECH ACAD: −$2.36, −$1.94, −$1.60, −$1.79, −$1.05, −$1.34, −$0.37, $1.36, $2.30 ACAD ADUS: $1.03, $1.33, $1.77, $2.08, $2.81, $2.84, $3.83, $4.23, $5.22 ADUS LIVN: −$0.52, −$3.91, −$3.26, −$7.18, −$2.68, −$1.61, $0.32, $1.16, −$4.45 LIVN PBH: $1.30, $6.34, −$0.69, $2.78, $3.25, $4.04, −$1.65, $4.17, $4.29 PBH PGNY: −$2.37, $0.04, −$0.41, $0.47, $0.66, $0.30, $0.62, $0.57, $0.65 PGNY
PGNY is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$21.90 to $6.34. A gap is a year with no number. A ring marks where a line starts: SHC has no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out PGNY and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: PGNY's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PGNY/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.